TrialThe journal of prevention of Alzheimer's disease2025

Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease.

Christopher Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.